At ESMO 2025, new data marked a major advance in breast cancer treatment. ADCs like trastuzumab deruxtecan and datopotamab deruxtecan significantly improved survival and reduced relapse...
Novo Nordisk Chairman Helge Lund, Vice Chairman Henrik Poulsen, and five independent directors resigned after disagreements with the Novo Nordisk Foundation, its majority shareholder. The Foundation...
Vytrus Biotech, whose stock has surged nearly 200% in 2025, will open a new production plant in Catalonia to support expansion and meet rising demand. Targeting...
The AstraZeneca Foundation awarded €1 million in its 9th Young Researchers Awards to support four Spanish scientific teams in fields like diabetes, oncology, and respiratory diseases....
A University of Barcelona study introduces a dual strategy for brain repair by combining stem cell therapy with sustained BDNF delivery. Using genetically modified human neural...
The GEICAM Breast Cancer Research Group reaffirms its leadership in Spanish oncology, according to SEOM’s 2024 report. With 108 clinical trials, 172 total studies, and 68,000...
NanoPhoria Bioscience has raised the first tranche of its €83.5 million Series A round, led by Xgen Venture, Sofinnova Partners, and CDP Venture Capital, marking Italy’s...
The 2025 Nobel Prize in Medicine was awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for discovering regulatory T cells, the “guardians” that prevent...
Siemens Healthineers has opened its first Southern Europe Center for the Adoption of AI in Healthcare in Madrid. With 120 experts collaborating with 300 hospitals across...
Foreomics, a Spanish preventive healthcare firm, created the first scientific tool predicting mortality and serious illness using a retrospective algorithm. Combining CT scans, blood tests, genetics,...